Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein.

The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is the molecular target for many vaccines and antibody-based prophylactics aimed at bringing COVID-19 under control. Such a narrow molecular focus raises the specter of viral immune evasion as a potential failure mode for these biomedical...

詳細記述

書誌詳細

主要な著者:	Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Uyen Tran, Bruce Zetter, Michael Rogers, Bradley L Pentelute, Jonathan M Carlson, Mark Hixon, Diane Joseph-McCarthy, Arijit Chakravarty
フォーマット:	Artigo
言語:	Inglês
出版事項:	Public Library of Science (PLoS) 2021-01-01
シリーズ:	PLoS ONE
オンライン･アクセス:	https://doi.org/10.1371/journal.pone.0250780
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!